Latest News

All the latest company news from Oxford Vacmedix

Cancer vaccine firm Oxford Vacmedix appoints PharmaLegacy as Contract Research Organisation

Oxford Vacmedix appoints Shanghai based PharmaLegacy to carry out the proof of concept work of both lead immunotherapy cancer vaccines, to support Phase 1 applications. Oxford Vacmedix UK Limited (OVM), the UK-based biopharma company focused on the development of cancer vaccines, announced today that PharmaLegacy of Shanghai, China has been appointed to complete the proof …

Cancer vaccine firm Oxford Vacmedix appoints PharmaLegacy as Contract Research OrganisationRead More »

Contact us

If you want to have a quick chat, or leave us some feedback,
you can contact us using any of the methods below